R S M Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 04-07-2024
- Paid Up Capital ₹ 1.50 Cr
as on 04-07-2024
- Company Age 35 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 49.00 Cr
as on 04-07-2024
- Satisfied Charges ₹ 52.88 Cr
as on 04-07-2024
- Revenue 29.47%
(FY 2023)
- Profit 15.54%
(FY 2023)
- Ebitda 23.09%
(FY 2023)
- Net Worth 72.46%
(FY 2023)
- Total Assets 19.40%
(FY 2023)
About R S M Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹49.00 Cr. The company has closed loans amounting to ₹52.88 Cr, as per Ministry of Corporate Affairs (MCA) records.
Prabhat Agrawal, Siddharth Upadhyay, and Muniswamy Gautham serve as directors at the Company.
- CIN/LLPIN
U85110KA1989PTC009974
- Company No.
009974
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 1989
- Date of AGM
04 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does R S M Pharma Private Limited offer?
R S M Pharma Private Limited offers a wide range of products and services, including Financial Service, Finance Consultant, Event Organizers, Corporate Event Management, Business Consultant, Sales Strategy Services, Lamps, Projection Lamps.
Who are the key members and board of directors at R S M Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhat Agrawal  | Director | 14-Aug-2018 | Current |
| Siddharth Upadhyay | Additional Director | 12-Aug-2023 | Current |
| Muniswamy Gautham | Director | 05-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of R S M Pharma.
R S M Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.47% increase. The company also saw a substantial improvement in profitability, with a 15.54% increase in profit. The company's net worth Soared by an impressive increase of 72.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of R S M Pharma?
In 2023, R S M Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Avenues Pharma Distributors Private LimitedActive 5 years 8 monthsPrabhat Agrawal, Siddharth Upadhyay and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Feb 2022 | ₹34.00 Cr | Open |
Others Creation Date: 31 May 2019 | ₹15.00 Cr | Open |
Others Creation Date: 31 Aug 2018 | ₹10.00 Cr | Satisfied |
How Many Employees Work at R S M Pharma?
R S M Pharma has a workforce of 255 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R S M Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R S M Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
